BioLife Solutions (NASDAQ:BLFS) vs. Generation Alpha (OTCMKTS:GNAL) Head-To-Head Review

BioLife Solutions (NASDAQ:BLFS) and Generation Alpha (OTCMKTS:GNAL) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

Analyst Recommendations

This is a summary of current ratings and price targets for BioLife Solutions and Generation Alpha, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLife Solutions	1	1	3	0	2.40
Generation Alpha	0	0	0	0	0.00

BioLife Solutions presently has a consensus price target of $32.00, indicating a potential upside of 31.47%. Given BioLife Solutions’ stronger consensus rating and higher probable upside, research analysts plainly believe BioLife Solutions is more favorable than Generation Alpha.

Institutional & Insider Ownership

93.2% of BioLife Solutions shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by company insiders. Comparatively, 60.8% of Generation Alpha shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Risk and Volatility

BioLife Solutions has a beta of 1.93, suggesting that its share price is 93% more volatile than the S&P 500. Comparatively, Generation Alpha has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500.

Profitability

This table compares BioLife Solutions and Generation Alpha’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioLife Solutions	-3.20%	0.97%	0.87%
Generation Alpha	N/A	N/A	N/A

Valuation and Earnings

This table compares BioLife Solutions and Generation Alpha”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLife Solutions	$82.25 million	14.25	-$20.18 million	($0.07)	-347.71
Generation Alpha	N/A	N/A	N/A	N/A	N/A

Generation Alpha has lower revenue, but higher earnings than BioLife Solutions.

Summary

BioLife Solutions beats Generation Alpha on 8 of the 10 factors compared between the two stocks.

About BioLife Solutions

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

About Generation Alpha

Generation Alpha, Inc. focuses on the research, design, development, and manufacturing of indoor horticulture lighting, plant nutrient products, and ancillary equipment in the United States and internationally. The company offers digital ballasts; metal halide, and mercury vapor and high-pressure sodium lamps; light emitting diode lighting products that produce less heat; digital lighting controller, a temperature monitoring control system; reflectors; and high intensity lighting accessories, as well as plant nutrients and fertilizers. It primarily serves commercial and retail cannabis growers in the medical and adult use recreational markets; distributors; and retailers. Generation Alpha, Inc. markets its products directly; and through distributors to hydroponic retailers, as well as through direct contacts, online email advertising, social media, trade magazine advertising, trade show promotions, and cross-promotional offerings, as well as ecommerce websites. The company was formerly known as Solis Tek Inc. Generation Alpha, Inc. was incorporated in 2007 and is based in Upland, California.